SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Haugland who wrote (56)2/14/1998 6:44:00 PM
From: Richard Haugland  Read Replies (1) of 359
 
Heavy insider selling in ABSC

Reports filed with the SEC showed 813,698 shares on form 144 filings in January at an average price of $12.95 and 720,566 shares in December at an average price of $13.48 mostly sold by "parties owning over 10% of the shares of the company." In addition there was a form 4 filed in January for 170,000 shares at an average price of $13.09. These reports may have been for sales in December and may not include all sales during January (or coming).

insidertrader.com

IMO, don't expect much price rise until these original investors are taken out by the public. The stock is too thinly traded to sustain a lot of big trades but should be good in the long run.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext